14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Automated image analysis detects aging in clinical-grade mesenchymal stromal cell cultures

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Senescent cells are undesirable in cell therapy products due to reduced therapeutic activity and risk of aberrant cellular effects, and methods for assessing senescence are needed. Early-passage mesenchymal stromal cells (MSCs) are known to be small and spindle-shaped but become enlarged upon cell aging. Indeed, cell morphology is routinely evaluated during MSC production using subjective methods. We have therefore explored the possibility of utilizing automated imaging-based analysis of cell morphology in clinical cell manufacturing.

          Methods

          An imaging system was adopted for analyzing changes in cell morphology of bone marrow-derived MSCs during long-term culture. Cells taken from the cultures at the desired passages were plated at low density for imaging, representing morphological changes observed in the clinical-grade cultures. The manifestations of aging and onset of senescence were monitored by population doubling numbers, expression of p16 INK4a and p21 Cip1/Waf1, β-galactosidase activity, and telomeric terminal restriction fragment analysis.

          Results

          Cell area was the most statistically significant and practical parameter for describing morphological changes, correlating with biochemical senescence markers. MSCs from passages 1 (p1) and 3 (p3) were remarkably uniform in size, with cell areas between 1800 and 2500 μm 2. At p5 the cells began to enlarge resulting in a 4.8-fold increase at p6–9 as compared to p1. The expression of p16 INK4a and activity of β-galactosidase had a strong correlation with the increase in cell area, whereas the expression of p21 Cip1/Waf1 reached its maximum at the onset of growth arrest and subsequently decreased. Mean telomere length shortened at an apparently constant rate during culture, from 8.2 ± 0.3 kbp at p1, reaching 6.08 ± 0.6 kbp at senescence.

          Conclusions

          Imaging analysis of cell morphology is a useful tool for evaluating aging in cell cultures throughout the lifespan of MSCs. Our findings suggest that imaging analysis can reproducibly detect aging-related changes in cell morphology in MSC cultures. These findings suggest that cell morphology is still a supreme measure of cell quality and may be utilized to develop new noninvasive imaging-based methods to screen and quantitate aging in clinical-grade cell cultures.

          Electronic supplementary material

          The online version of this article (10.1186/s13287-017-0740-x) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: not found

          Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals.

          Mesenchymal stem cells (MSCs) are largely studied for their potential clinical use. Recently, they have gained further interest after demonstration of an immunosuppressive role. In this study, we investigated whether in vivo injection of MSCs could display side effects related to systemic immunosuppression favoring tumor growth. We first showed in vitro that the murine C3H10T1/2 (C3) MSC line and primary MSCs exhibit immunosuppressive properties in mixed lymphocyte reaction. We demonstrated that this effect is mediated by soluble factors, secreted only on "activation" of MSCs in the presence of splenocytes. Moreover, the immunosuppression is mediated by CD8+ regulatory cells responsible for the inhibition of allogeneic lymphocyte proliferation. We then demonstrated that the C3 MSCs expressing the human bone morphogenetic protein 2 (hBMP-2) differentiation factor were not rejected when implanted in various allogeneic immunocompetent mice and were still able to differentiate into bone. Importantly, using a murine melanoma tumor model, we showed that the subcutaneous injection of B16 melanoma cells led to tumor growth in allogeneic recipients only when MSCs were coinjected. Although the potential side effects of immunosuppression induced by MSCs have to be considered in further clinical studies, the usefulness of MSCs for various therapeutic applications still remains of great interest.
            • Record: found
            • Abstract: found
            • Article: not found

            The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability.

            Loss of telomere function can induce cell cycle arrest and apoptosis. To investigate the processes that trigger cellular responses to telomere dysfunction, we crossed mTR-/- G6 mice that have short telomeres with mice heterozygous for telomerase (mTR+/-) that have long telomeres. The phenotype of the telomerase null offspring was similar to that of the late generation parent, although only half of the chromosomes were short. Strikingly, spectral karyotyping (SKY) analysis revealed that loss of telomere function occurred preferentially on chromosomes with critically short telomeres. Our data indicate that, while average telomere length is measured in most studies, it is not the average but rather the shortest telomeres that constitute telomere dysfunction and limit cellular survival in the absence of telomerase.
              • Record: found
              • Abstract: found
              • Article: not found

              Measurement of telomere length by the Southern blot analysis of terminal restriction fragment lengths.

              In this protocol we describe a method to obtain telomere length parameters using Southern blots of terminal restriction fragments (TRFs). We use this approach primarily for epidemiological studies that examine leukocyte telomere length. However, the method can be adapted for telomere length measurements in other cells whose telomere lengths are within its detection boundaries. After extraction, DNA is inspected for integrity, digested, resolved by gel electrophoresis, transferred to a membrane, hybridized with labeled probes and exposed to X-ray film using chemiluminescence. Although precise and highly accurate, the method requires a considerable amount of DNA (3 μg per sample) and it measures both the canonical and noncanonical components of telomeres. The method also provides parameters of telomere length distribution in each DNA sample, which are useful in answering questions beyond those focusing on the mean length of telomeres in a given sample. A skilled technician can measure TRF length in ∼130 samples per week.

                Author and article information

                Contributors
                +358-50-3820290 , sofia.oja@helsinki.fi
                pauno.komulainen@helsinki.fi
                antti.i.penttila@helsinki.fi
                johanna.nystedt@bloodservice.fi
                matti.korhonen@bloodservice.fi
                Journal
                Stem Cell Res Ther
                Stem Cell Res Ther
                Stem Cell Research & Therapy
                BioMed Central (London )
                1757-6512
                10 January 2018
                10 January 2018
                2018
                : 9
                : 6
                Affiliations
                [1 ]ISNI 0000 0000 9387 9501, GRID grid.452433.7, Advanced Cell Therapy Centre, Finnish Red Cross Blood Service, ; Kivihaantie 7, FI-00310 Helsinki, Finland
                [2 ]ISNI 0000 0004 0410 2071, GRID grid.7737.4, Institute of Biomedicine, Department of Anatomy, , University of Helsinki, ; Haartmaninkatu 8, FI-00290 Helsinki, Finland
                [3 ]ISNI 0000 0004 0410 2071, GRID grid.7737.4, Department of Physics, , University of Helsinki, ; P.O. Box 64, FI-00014 Helsinki, Finland
                [4 ]ISNI 0000 0000 9950 5666, GRID grid.15485.3d, Division of Hemato-Oncology and Stem Cell Transplantation, Hospital for Children and Adolescents, , Helsinki University Central Hospital, ; FI-00290 Helsinki, Finland
                Author information
                http://orcid.org/0000-0001-8226-0102
                Article
                740
                10.1186/s13287-017-0740-x
                5763576
                29321040
                4b843ade-8d20-43f6-b34f-aea25894f0a8
                © The Author(s). 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 16 June 2017
                : 28 November 2017
                : 1 December 2017
                Funding
                Funded by: Väre Foundation for Pediatric Cancer Research
                Funded by: Punainen Risti Veripalvelu (FI), EVO Medical Research
                Categories
                Research
                Custom metadata
                © The Author(s) 2018

                Molecular medicine
                mesenchymal stromal cells,msc,aging,senescence,quality control,morphology,imaging,cell manufacturing,cell therapy

                Comments

                Comment on this article

                Related Documents Log